|
October 7, 2002
Prolinx Inc. Announces Distribution Agreement with
VWR International for RapXtract Superparamagnetic Separation
Technology
Bothell, WA, USA – Prolinx, Inc. today announced
that it has signed a distribution agreement with VWR
International of West Chester, Pennsylvania. VWR, a
leading worldwide distributor of scientific equipment,
supplies, chemicals and furniture, will distribute the
Prolinx RapXtract® Superparamagnetic Separation
Technology and accessories in the United States and
Canada. RapXtract separation technology is used in DNA
sequencing and gene expression arrays used widely in
life science research and biotechnology.
RapXtract Superparamagnetic Technology is based upon
proprietary superparamagnetic particles that use mass
action to remove dye labeled precursors from nucleic
acid labeling reactions. The technology presents a paradigm
shift for purification due to its unique method. The
technology "reverse purification" enables
full automation, reduces sample-processing time and
allows for minimum sample volumes as required by high
throughput laboratories for use in applications such
as whole genome analysis, single-nucleotide polymorphism
discovery, drug discovery research, toxicology analysis
and pharmacogenomics. Prolinx currently offers two product
lines based upon the RapXtract Technology, RapXtract
Dye Terminator Removal Kits and RapXtract Fluorescent
Nucleic Acid Purification Kit.
"Accessing the supply chain management capabilities
of a world class distribution organization like VWR
International is essential for a company with leading
edge technology like Prolinx," stated Jim Mahoney,
president and CEO, Prolinx, Inc. "We expect this
agreement to significantly impact our market penetration
and revenue going forward."
"Prolinx is a truly innovative company and we
at VWR look forward to this relationship," stated
Ed Sapp, Director of Marketing for Life Sciences at
VWR International.
VWR International is a global leader in Life Science
laboratory product distribution serving the industrial,
pharmaceutical, educational and governmental markets.
VWR also provides Production Supplies and Services to
meet the needs of electronic and pharmaceutical production.
The VWR International Group is headquartered in West
Chester, Pennsylvania, and generates annual sales of
US $2.5 billion. VWR International operates in 18 countries
and employs more than 6,000 people. VWR's mission is
to deliver excellence in the distribution of scientific
supplies. .
Prolinx, founded in 1995, is a privately held biotechnology
company located north of Seattle, Washington, USA. The
company develops, manufactures, and markets chemistry
based tools, applications, and systems that advance
developments in bioresearch, biotechnology and drug
discovery. The company has commercialized a number of
proprietary technologies including: Versalinx Chemical
Affinity Tools, a synthetic chemical affinity technology
targeted at the proteomics and genomics markets; Versalinx
Protein Microarray Technology, a novel open platform
array system specifically designed to enable developments
in the emerging protein and peptide chip market; and
RapXtract Superparamagnetic Separation Technology for
the purification of fluorescent labeling reactions used
in sequencing and microarray applications. The company
is also developing instrumentation for label-free molecular
interaction analysis based upon advances in surface
plasmon resonance technology. The first instrument,
the Octave Molecular Interaction Analysis System, will
be released in 2002.
Prolinx is a registered trademark, and Octave, and
Versalinx are trademarks, of Prolinx, Inc.
Contact:
Leslie Linkkila
Director, Sales & Marketing
Prolinx, Inc.
22322 20th Ave SE Bothell, WA 98021
Phone: 425-487-3401
Fax: 425-487-9578
Email: leslie.linkkila@prolinx.com
Web: www.prolinx.com
|
